Vaccines for TB: Lessons from the Past Translating into Future Potentials - Wikidata - awgldk - TriplyDB

Vaccines for TB: Lessons from the Past Translating into Future Potentials

Vaccines for TB: Lessons from the Past Translating into Future Potentials

http://www.wikidata.org/entity/Q26996673

about

Mycobacterium tuberculosis Zinc Metalloprotease-1 Elicits Tuberculosis-Specific Humoral Immune Response Independent of Mycobacterial Load in Pulmonary and Extra-Pulmonary Tuberculosis Patients.Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.

P2860

Q36747054-FBA4F7CA-CBC6-4243-A60D-2205FEC149B3 Q55091455-2A990F95-A8DA-46D0-A0BA-53B222885444

P2860

Vaccines for TB: Lessons from the Past Translating into Future Potentials

http://www.wikidata.org/entity/Q26996673

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@ast

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@en

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@nl

type

label

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@ast

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@en

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@nl

prefLabel

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@ast

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@en

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@nl

P1433

Q26996673-09909BD3-C613-4B17-B1AB-0AF86C0461D8

P1476

Q26996673-DCE7B244-19E5-4CE9-A4BC-12BD6FA5BA12

P2093

Q26996673-3F9D7D62-72A6-4E3E-B961-F2B76B76B2FC

Q26996673-4431B736-E9D6-44A6-940D-8EAFE635C73F

Q26996673-C37EDC47-2E95-4042-890A-2892AC25585B

P275

Q26996673-E61AF9C9-A807-4EE5-A0D6-2B88AA91AC50

P2860

Q26996673-026A67A9-9CC3-4745-A91B-10B7D60934C3

Q26996673-0EAFFFDF-09AD-4C22-ACD2-B948476A679D

Q26996673-1366DBE7-4DB2-40DB-830D-A84A51DD07F7

Q26996673-13957D00-8E4A-4DFB-9C2B-07B3D55D1AB5

Q26996673-1477D37B-F957-47A0-BC19-5578A9381926

Q26996673-1628C5E5-D67D-4E04-BD9D-D6BFD44BAB18

Q26996673-16E5AB12-540F-4678-857B-6558DD4BF164

Q26996673-17BCD5A9-BB2D-40C5-BFA5-AF754AD921CD

Q26996673-1805FAD9-1C75-471E-87CE-A1DEF531E975

Q26996673-1C103BCA-2CD0-4BF7-87AA-50B0C607193A

P304

Q26996673-9D7D6427-E3A0-4A58-A8BC-9C43951AD42E

P31

Q26996673-7931E962-6F8C-4269-9EE4-8E926D8A4296

Q26996673-A3E1A1E1-54FB-4151-A596-15AB61A0CA75

P3181

Q26996673-62A39DEE-FD5E-470E-B9BE-0EBBA2AFA0F8

P356

Q26996673-FA3B2533-595B-4ACE-8D35-1B3434B7DA1E

P407

Q26996673-991F9065-794F-4AE8-80D0-B2CE2ED2BDD7

P478

Q26996673-983CA85E-5E5A-456D-B1E0-2C837755CB57

P50

Q26996673-531F9A8D-50B0-4B29-8F12-CEEDF128EBB8

Q26996673-735B9A78-7C4A-4A4A-AEB8-26790B1AA4E9

Q26996673-98526129-9AED-4D8A-BC18-E70F4BEF8784

Q26996673-E2502C5A-534A-4332-95A4-38B9CB4C25A7

P577

Q26996673-43EB4C69-BEB6-44AC-9F73-38B00C94B1CA

Q26996673-9361225D-3D89-47B3-A3F5-7FD4A44D025C

P5875

Q26996673-82B387E1-596C-4A2C-A501-6DFEA6BA89AB

P698

Q26996673-896B3E2F-F23F-4A6F-B8A5-C8A7C2EA5D65

P921

Q26996673-A13A3BE3-98BC-41C5-BF2F-4ABAFCA54BE9

Q26996673-BB4AAFA8-D553-4284-B659-D80FB92E75AF

P932

Q26996673-538851F6-B136-421C-B018-E71C7FE9129D

P3181

P356

P1433

Journal of Immunology Research

P1476

Vaccines for TB: Lessons from the Past Translating into Future Potentials

@en

P2093

Min Han Lew

http://www.w3.org/2001/XMLSchema#string

Mohd Nor Norazmi

http://www.w3.org/2001/XMLSchema#string

Yee Siew Choong

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Future Vaccination Strategies against Tuberculosis: Thinking outside the Box

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis

Vaccine development for tuberculosis: current progress

Recent advances towards tuberculosis control: vaccines and biomarkers

Vaccines against tuberculosis: where are we and where do we need to go?

A conserved human T cell population targets mycobacterial antigens presented by CD1b

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3

The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis

P304

916780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4966249

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2015/916780

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

María E Sarmiento

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280571347

http://www.w3.org/2001/XMLSchema#string

P698

26146643

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

4469767

http://www.w3.org/2001/XMLSchema#string